Associations of Vitamin D Receptor Single Nucleotide Polymorphisms with Susceptibility to Systemic Sclerosis.

[1]  S. Gangemi,et al.  Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications. , 2019, Autoimmunity reviews.

[2]  C. Girgis.  Vitamin D and Skeletal Muscle: Emerging Roles in Development, Anabolism and Repair , 2019, Calcified Tissue International.

[3]  L. Saraswathy,et al.  Association between vitamin D and hypertension in people coming for health check up to a tertiary care centre in South India , 2019, Journal of family medicine and primary care.

[4]  Maurizio Cutolo,et al.  Pathophysiology of systemic sclerosis: current understanding and new insights , 2019, Expert review of clinical immunology.

[5]  A. Hammad,et al.  Oxidative stress and vitamin D receptor BsmI gene polymorphism in Egyptian children with systemic lupus erythematosus: a single center study , 2019, Lupus.

[6]  N. Sheikh,et al.  Vitamin D Receptor Gene Polymorphism: An Important Predictor of Arthritis Development , 2019, BioMed research international.

[7]  J. Chudek,et al.  Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker , 2018, Journal of clinical medicine.

[8]  F. Główka,et al.  Genetic Determinants of Vitamin D-Related Disorders; Focus on Vitamin D Receptor. , 2018, Current drug metabolism.

[9]  F. Ingegnoli,et al.  Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis. , 2018, Best practice & research. Clinical rheumatology.

[10]  K. Hamzaoui,et al.  FGF 23, PTH and vitamin D status in end stage renal disease patients affected by VDR FokI and BsmI variants. , 2018, Clinical biochemistry.

[11]  J. Gu,et al.  Association between vitamin D receptor gene polymorphism and ankylosing spondylitis in Han Chinese , 2017, International journal of rheumatic diseases.

[12]  D. Ye,et al.  Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study , 2017, International journal of rheumatic diseases.

[13]  R. Hassan,et al.  Vitamin D receptor Fok1 & Bsm 1 Gene Polymorphisms in Systemic Lupus Erythematosus and Osteoarthritis: Autoimmune Inflammatory versus Degenerative Model. , 2017, The Egyptian journal of immunology.

[14]  I. Siam,et al.  Association of VDR ApaI and TaqI Gene Polymorphisms with the Risk of Scleroderma and Behçet’s Disease , 2016, Immunological investigations.

[15]  R. Mahfouz,et al.  Vitamin D receptor biochemical and genetic profiling and HLA-class II genotyping among Lebanese with multiple sclerosis — A pilot study , 2016, Journal of Neuroimmunology.

[16]  Chong Shen,et al.  Vitamin D Receptor Genetic Polymorphism Is Significantly Associated with Risk of Type 2 Diabetes Mellitus in Chinese Han Population. , 2015, Archives of medical research.

[17]  Y. H. Lee,et al.  Vitamin D receptor FokI, BsmI, and TaqI polymorphisms and susceptibility to rheumatoid arthritis , 2015, Zeitschrift für Rheumatologie.

[18]  K. Tizaoui,et al.  Association between VDR polymorphisms and rheumatoid arthritis disease: Systematic review and updated meta-analysis of case-control studies. , 2015, Immunobiology.

[19]  G. Schett,et al.  Vitamin D receptor regulates TGF-β signalling in systemic sclerosis. , 2015, Annals of the rheumatic diseases.

[20]  E. Hsieh,et al.  Clinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China. , 2014, Clinical and experimental rheumatology.

[21]  J. Pablos,et al.  Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma , 2014, Archives of Dermatological Research.

[22]  G. Papp,et al.  Lack of association of vitamin D receptor gene polymorphisms/haplotypes in Sjögren’s syndrome , 2014, Clinical Rheumatology.

[23]  A. F. Zimmermann,et al.  Update on etiopathogenesis of systemic sclerosis. , 2013, Revista brasileira de reumatologia.

[24]  M. Gershwin,et al.  The Implication of Vitamin D and Autoimmunity: a Comprehensive Review , 2013, Clinical Reviews in Allergy & Immunology.

[25]  P. Jagodziński,et al.  Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus , 2012, Molecular Biology Reports.

[26]  M. Khanfir,et al.  Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behçet's disease in Tunisians. , 2012, Joint, bone, spine : revue du rhumatisme.

[27]  J. Damoiseaux,et al.  Effects of vitamin D on the peripheral adaptive immune system: a review. , 2011, Autoimmunity reviews.

[28]  Sneha S. Joshi,et al.  1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A , 2011, Molecular and Cellular Biology.

[29]  C. Davis.  Vitamin D and cancer: current dilemmas and future research needs. , 2008, The American journal of clinical nutrition.

[30]  K. Badenhoop,et al.  The vitamin D receptor gene FokI polymorphism: Functional impact on the immune system , 2007, European journal of immunology.

[31]  A. Uitterlinden,et al.  Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[33]  N Rowell,et al.  Systemic sclerosis. , 1968, British medical journal.